Surveillance of cryptococcosis in Alabama, 1992-1994

Annals of Epidemiology

Volumn 8, Issue 4, 1998, Pages 212-216

  Thomas, Carolynn J ^a   Lee, Jeannette Y ^a   Conn, Laura A ^c,d   Bradley, Mary E ^a   Gillespie, Roger W ^a   Dill, S Reeves ^b   Pinner, Robert W ^c   Pappas, Peter G ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d TRW Govt Info Services Division   (United States)

Author keywords

Acquired Immunodeficiency Syndrome; Cryptococcosis; Cryptococcus neoformans; Epidemiology; Fungus; Incidence; Meningitis; Surveillance

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; FUNGAL MENINGITIS; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SERODIAGNOSIS; UNITED STATES;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALABAMA; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE;

EID: 0031958853     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(97)00234-2     Document Type: Article

References (35)

1. Levitz SM The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 13:1991;163-169.
2. Perfect JR Cryptococcosis. Infect Dis Clin North Am. 3(1):1989;77-93.
3. Aikat BK, Chatterjee BD, Banerjee PL The rising incidence of cryptococcosis. Indian J Med Res Inf Dis. 55(1):1967;43-46.
4. Reingold AL, Lu XD, Plikaytis BD, Ajello L Systemic mycoses in the United States, 1980-1982. J Med Vet Mycol. 24:1986;433-436.
5. Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak Het al. Fungal infections in cancer patients. An international autopsy survey Eur J Clin Microbiol Infect Dis. 11(2):1992;99-109.
6. Pillay VKG, Wilson DM, Ing TS, Kark RM Fungus infection in steroid-treated systemic lupus erythematosus. JAMA. 205(5):1968;261-267.
7. Sieving RR, Kauffman CA, Watanakunakorn C Deep fungal infection in systemic lupus erythematosus - three cases reported, literature reviewed. J Rheum. 2(1):1975;61-72.
8. Shaariah W, Morad Z, Suleiman AB Cryptococcosis in renal transplant recipients. Transpl Proc. 24(5):1992;1898-1899.
9. Kong NCT, Shaariah W, Morad Z, Suleiman AB, Wong YH Cryptococcosis in a renal unit. Aust NZ J Med. 20:1990;645-649.
10. Dismukes WE Cryptococcal meningitis in patients with AIDS. J Infect Dis. 157:1988;624-628.
11. Kovacs JA, Kovacs AA, Polis Met al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med. 103:1985;533-538.
12. Saag MS, Powderly WG, Cloud GAet al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med. 326:1992;83-89.
13. Bullock W, Kozel T, Scherer S, Dixon DM Medical mycology in the1990s. Involvement of NIH and the wider community ASM News. 59(4):1993;182-185.
14. Zugar A, Louie E, Holzmann RS, Siberkoff MS, Rahal JJ Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med. 104:1986;234-240.
15. Eng RH, Bishburg E, Smith SM, Kapila R Cryptococcal infections in patients with acquired immunodeficiency syndrome. Am J Med. 81:1986;19-23.
16. Powderly WG, Saag MS, Cloud GAet al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 326:1992;793-798.
17. Butler WT, Alling DW, Spinkard A, Utz JP Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis. N Engl J Med. 270:1964;59-67.
18. Lewis JL, Rabinovich S The wide spectrum of cryptococcal infections. Am J Med. 53:1972;315-322.
19. Sarosi GA, Parker JD, Doto IL, Tosh FE Amphotericin B in cryptococcal meningitis. long term results of treatment Ann Intern Med. 71:1969;1079-1087.
20. Mosberg WH, Arnold JG Torulosis of the central nervous system. reviews of literature and report of five cases Ann Intern Med. 32:1950;1153-1183.
21. Luchi MJ, DiBona D, Popma G, Munford RS, Haley RW Urban cryptococcal disease in the pre-AIDS era (abstract). Program and Abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy:1989;17-20. Houston, Tx. September , . Washington D.C.: American Society for Microbiology; 1989 (Abstract 526):188.
22. Horsburgh CR, Selik RM. Extrapulmonary cryptococcosis in AIDS patients: Risk factors and associations with decreased survival (abstract). In: Program and Abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. October 23-26, 1988. Washington D.C.: American Society for Microbiology; 1988 (Abstract 564):207.
23. Castro KG, Selik RM, Jaffe HW, Dondero TJ, Curran JW. Frequency of opportunistic diseases in AIDS patients, by race/ethnicity and HIV transmission categories - United States (abstract). In: Program and Abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. October 23-26, 1988. Washington D.C.:American Society for Microbiology; 1988 (Abstract 570):208.
24. Hajjeh RN, Brandt ME, Pinner RW Emergence of cryptococcal disease. Epidemiologic perspectives 100 years after its discovery Epidemiol Rev. 17:1995;303-320.
25. Brandt ME, Hutwagner LC, Klug LA, Baughman WS, Rimland D, Graviss EAet al. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. J Clin Micro. 34:1996;912-917.
26. Brandt ME, Bragg SL, Pinner RW Multilocus enzyme typing of Cryptococcus neoformans. J Clin Micro. 31(10):1993;2819-2823.
27. U.S. Department of Commerce, Bureau of Census. 1990 Census of Population and Housing, STF 3. Alabama State Data Center, The University of Alabama, Tuscaloosa, Alabama.
28. Currie BP, Casadevall A Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis. 19:1994;1029-1033.
29. Fraser DW, Ward JI, Ajello L, Plikaytis BD Aspergillosis and other systemic mycoses. The growing problem JAMA. 242:1979;1631-1635.
30. Rozenbaum R, Goncalves AJ Clinical epidemiologic study of 171 cases of cryptococcosis. Clin Infect Dis. 18:1994;369-380.
31. Powderly WG, Finkelstein DM, Feinburg Jet al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med. 332:1995;700-705.
32. Cluckmeck N Primary prophylaxis against opportunistic infections in patients with AIDS. N Engl J Med. 332:1995;739-740.
33. Gallant JE, Moore RD, Chaisson RE Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 120:1994;932-944.
34. Cameron ML, Schell WA, Bruch Set al. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type I. Antimicrob Agents Chemother. 37:1993;2449-2453.
35. Hajjeh RA, Klug LA, Farley M, Baughman W, Hamill R, et al. Cryptococcosis in the United States: Prospective, population-based active surveillance and risk factors in HIV-infected persons. 1997; In press.